Skip to main content

Tyra Biosciences

Tyra Biosciences Inc is an American clinical-stage biopharmaceutical enterprise headquartered in Carlsbad, California. The company specializes in the discovery and development of precision oncology therapeutics designed to address acquired drug resistance in targeted cancer therapies. Its proprietary SNÅP platform utilizes iterative chemistry approaches to design selective fibroblast growth factor receptor (FGFR) inhibitors. Principal revenue is currently earned through strategic pharmaceutical research collaborations and capital financing arrangements. Tyra Biosciences Inc is publicly listed on the Nasdaq Stock Market.

2 of the funds FundTelligence covers report a position in Tyra Biosciences.

Legal name
Tyra Biosciences Inc
Sector
Health Care
Country
United States
Funds holding it
2

Funds holding Tyra Biosciences

Loading...